期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 31, 期 6, 页码 266-276出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2010.04.001
关键词
-
资金
- BBSRC [BB/E52708X/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: Medline
Ischaemia-reperfusion (I/R) injury is a common feature of several diseases associated with high morbidity and mortality, such as stroke and myocardial infarction. The damaged tissue displays cardinal signs of inflammation and microvascular injury that, unless resolved, lead to long-term tissue damage with associated dysfunction. Current therapies are limited and are often associated with many side effects. Increasing evidence suggests that members of the formyl peptide receptor (FPR) family, in particular human FPR2/ALX, might have an important role in the pathophysiology of I/R injury. It was recently demonstrated that several peptides and non-peptidyl small-molecule compounds have anti-inflammatory and pro-resolving properties via their action on members of the FPR family. Here I review this evidence and suggest that FPR ligands, particularly in the brain, could be novel and exciting anti-inflammatory therapeutics for the treatment of a variety of clinical conditions, including stroke.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据